Browse > Article
http://dx.doi.org/10.5012/bkcs.2011.32.7.2433

Molecular Docking, 3D QSAR and Designing of New Quinazolinone Analogues as DHFR Inhibitors  

Yamini, L. (Department of Chemistry, Nizam College, Osmania University)
Kumari, K. Meena (Department of Chemistry, Nizam College, Osmania University)
Vijjulatha, M. (Department of Chemistry, Nizam College, Osmania University)
Publication Information
Abstract
The three dimensional quantitative structure activity relationship (3D QSAR) models were developed using Comparative molecular field analysis (CoMFA), comparative molecular similarity indices analysis (CoMSIA) and docking studies. The fit of Quinazolinone antifolates inside the active site of modeled bovine dihydrofolate reductase (DHFR) was assessed. Both ligand based (LB) and receptor based (RB) QSAR models were generated, these models showed good internal and external statistical reliability that is evident from the $q^2_{loo}$, $r^2_{ncv}$ and $r^2_{pred}$. The identified key features enabled us to design new Quinazolinone analogues as DHFR inhibitors. This study is a building bridge between docking studies of homology modeled bovine DHFR protein as well as ligand and target based 3D QSAR techniques of CoMFA and CoMSIA approaches.
Keywords
Dihydrofolate Reductase (DHFR); Three dimensional quantitative structure activity relationship (3D QSAR); Ligand Based (LB); Receptor Based (RB); Comparative molecular field analysis (CoMFA); Comparative molecular similarity indices analysis (CoMSIA);
Citations & Related Records

Times Cited By Web Of Science : 0  (Related Records In Web of Science)
Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Trimble, J. J.; Murthy, S. C. S.; Bakker, A.; Grassmann, R.;Desrosiers, R. C. Science 1988, 239, 1145.   DOI
2 Collin, J. Suckling, Enzyme Chemistry; Chapman and Hall Ltd.: 733 Third Avenue, NY, 1984; p 121.
3 Suresha, G. P.; Prakasha, K. C.; Kapfo, W.; Gowda, D. C. E-J Chem. 2010, 7(2), 449.   DOI
4 Alagarsamy, V.; Muthukumar, V.; Pavalarani, N.; Vasanthanathan,P.; Revathi, R. Biol. Pharm. Bull. 2003, 26(4), 557.   DOI   ScienceOn
5 Mani, C. P.; Yakaiah, T.; Raghu, R. R. A.; Narsaiah, B.; ChakraReddy, N.; Sridhar, V.; Venkateshwara, R. J. Eur. J. Med. Chem. 2007, 42, 147.
6 Rarey, M.; Kramer, B.; Lengauer, T.; Kleb, G. A. J. Mol. Biol. 1996, 261, 470.   DOI   ScienceOn
7 Balazs, J.; Arpad, M. J. Mol. Grap. And Model 2007, 25, 711.   DOI   ScienceOn
8 Cramer, R. D., III.; Patterson, D. E.; Bunce, J. D. J. Am. ChemSoc. 1988, 110, 5959.   DOI   ScienceOn
9 Cramer, R. D., III.; Bunce, J. D.; Patterson, D. E. Quant. Struct. Act. Relat. 1988, 7, 18.   DOI
10 Klebe, G.; Abraham, U.; Mietzner, T. J. Med. Chem 1994, 37, 4130.   DOI
11 Altschul, S. F.; Gish, W.; Miller, W.; Myers, E. W.; Lipman, D. J. J. Mol. Biol. 1990, 215, 403.   DOI
12 Altschul, S. F.; Thomas, L. M.; Alejandro, A. S.; Jinghui, Z.;Zheng, Z.; Miller, W.; Lipman, D. J. Nucleic Acids Res. 1997, 25,3389.   DOI
13 Balazs, J.; Arpad, M. J. Mol. Grap. and Model. 2007, 25, 711.   DOI   ScienceOn
14 Sali, A.; Blundell, T. L. J. Mol. Biol. 1993, 234, 779.   DOI   ScienceOn
15 Bowie, J. U.; Lüthy, R.; Eisenberg, D. Science 1991, 253, 164.   DOI
16 Sippl, M. J. Proteins 1993, 17, 355.   DOI   ScienceOn
17 Marti-Renom, M. A.; Stuart, A. C.; Fiser, A.; Sanchez, R.; Melo, F.; Sali, A. Annu. Rev. Biophys. Biomol. Struct. 2000, 29, 291.   DOI   ScienceOn
18 Laskowski, R. A.; Mac, A. M. W.; Moss, D. S.; Thornton, J. M. J. Appl. Cryst. 1993, 26, 283.   DOI   ScienceOn
19 Luthy, R.; Bowie, J. U.; Eisenberg, D. Nature 1992, 356, 83.   DOI   ScienceOn
20 Wiederstein & Sippl Nucleic Acid Res. 2007, 35, W407.   DOI
21 Sali, A.; Kurian, J. Trends Biochem. Sci. 1999, 22, M20.
22 SYBYL Molecular Modeling System, version 6.9, Tripos Inc., St. Louis, MO, 63144.
23 Gasteiger, J.; Marsili, M. Tetrahedron 1980, 363, 3219.
24 Stitch, I.; Car, R.; Parrinello, M.; Baroni, S. Phys. Rev. B 1989, 39,4997.   DOI   ScienceOn
25 Leach, A. Molecular Modelling, Principles and Applications;Longman: Harlow, Essex, England, 1996.
26 Forcefield-Based Simulations; Accelerys, Corp.: San Diego, CA.Chapter 4, Minimization.
27 Jensen, F. Introduction to Computational Chemistry; John Wiley:Chichester, England, 1999; p 322.
28 Ravishankar, C. H.; Devender, R. A.; Bhaskar, R. A.; Malla, R. V.; Sattur, P. B. Curr. Sci. 1984, 53, 1069.
29 Ouyang, G.; Zhang, P.; Xu, G.; Song, B.; Yang, S.; Jin, L.; Xue,W.; Hu, D.; Lu, P.; Chen, Z. Molecules 2006, 11, 383.   DOI
30 Martin, T. A.; Wheller, A. G.; Majewski, R. F.; Corrigan, J. R. J. Med. Chem. 1964, 7, 812.   DOI
31 Dienei, J. B.; Dowalo, F.; Hoeven, H. V.; Bender, P.; Loev, B. J. Med. Chem. 1973, 16, 633.   DOI
32 Jatav, V.; Mishra, P.; Kashaw, S.; Stables, J. P. Eur. J. Med. Chem. 2008, 4, 135.
33 Ilangovan, P.; Ganguly, S.; Pandi, V. J. Pharm. Res. 2010, 3, 703.
34 Chandrasekhar, V.; Raghurama, R. A.; Malla, R. V. Indian Drugs 1986, 3, 24.
35 Naithani, P. K.; Gautam, P.; Srivastava, V. K.; Shankar, K. Indian J. Chem. 1989, 28B, 745.
36 Magnus, N. A.; Confalone, P. N.; Storace, L.; Patel, M.; Wood, C. C.; Davis, W. P.; Parsons, R. L. J. Org. Chem. 2003, 68, 754.   DOI   ScienceOn
37 Jantova, S.; Urbancikova, M.; Maliar, T.; Mikuldsova, M.; Rauko,P.; Cipak, L.; Kubikova, J.; Stankovsky, S.; Spirkova, K.Neoplasm. 2001, 48, 52.
38 Sarah, T. R.; Ihsan, A.; Aboldahab et al. Bio. Org. Med. Chem. 2006, 14, 8608.   DOI   ScienceOn
39 Klebe, G.; Abraham, U.; Mietzner, T. J. Med. Chem. 1994, 37, 4130.   DOI
40 Wold, S.; Ruhe, A.; Wold, H.; Dunn, W. J. I. SIAM J. Sci. Stat. Comput. 1984, 5, 735.   DOI
41 Cavalli, A.; Greco, G.; Novelliono, E.; Recanatini, M. Boiorg. Med. Chem. 2000, 8, 2771.   DOI   ScienceOn
42 Boeckmann, B.; Bairoch, A.; Apwweiler, R.; Blatter, M. C.; Estreicher, A.; Gasteiger, E.; Martin, M. J.; Michoud, K.; O’Doonovan, C.; Phan, I.; Pilbout, S.; Schneider, M. Nucl. Acids Res. 2003, 31, 365.   DOI   ScienceOn